Page last updated: 2024-11-02

pantoprazole and Asystole

pantoprazole has been researched along with Asystole in 2 studies

Pantoprazole: 2-pyridinylmethylsulfinylbenzimidazole proton pump inhibitor that is used in the treatment of GASTROESOPHAGEAL REFLUX and PEPTIC ULCER.
pantoprazole : A member of the class of benzimidazoles that is 1H-benzimidazole substituted by a difluoromethoxy group at position 5 and a [(3,4-dimethoxypyridin-2-yl)methyl]sulfinyl group at position 2.

Research Excerpts

ExcerptRelevanceReference
" These results may influence drug choice and dosing of similarly metabolized drugs and may be helpful for designing studies in similar clinical situations."1.72Targeted temperature management after cardiac arrest is associated with reduced metabolism of pantoprazole - A probe drug of CYP2C19 metabolism. ( Clodi, C; Herkner, H; Holzer, M; Jilma, B; Mueller, M; Poppe, M; Rechenmacher, M; Reiter, B; Schoergenhofer, C; Schriefl, C; Schwameis, M; Sunder-Plaßmann, R; van Hasselt, JGC; van Os, W; Weiser, C, 2022)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Poppe, M1
Clodi, C1
Schriefl, C1
Mueller, M1
Sunder-Plaßmann, R1
Reiter, B1
Rechenmacher, M1
van Os, W1
van Hasselt, JGC1
Holzer, M1
Herkner, H1
Schwameis, M1
Jilma, B1
Schoergenhofer, C1
Weiser, C1
Dohr, J1
Hunzelmann, N1
Brown, A1

Other Studies

2 other studies available for pantoprazole and Asystole

ArticleYear
Targeted temperature management after cardiac arrest is associated with reduced metabolism of pantoprazole - A probe drug of CYP2C19 metabolism.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2022, Volume: 146

    Topics: Area Under Curve; Cytochrome P-450 CYP2C19; Female; Half-Life; Heart Arrest; Humans; Hypothermia, In

2022
[Immediate type reactions to proton pump inhibitors using pantoprazole and omeprazole as examples].
    Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 2018, Volume: 69, Issue:2

    Topics: Administration, Oral; Anaphylaxis; Cross Reactions; Drug Eruptions; Drug Hypersensitivity; Female; H

2018